/TSHA

Taysha Gene Therapies Inc

TSHA

$5.02USD↓-2.71%-0.14 today

MARKET CAP

1.6B

P/E (TTM)

—

FWD P/E

—

DAY RANGE

$5 – $5

52W RANGE

$3

$7

AI Summary

Stalk

TrimMedium

TSHA remains in medium-term distribution with active lower highs and lower lows under declining EMAs, trading near extreme oversold levels at the 200-day SMA. The medium-term bias is bearish, but short-term exhaustion and oversold RSI suggest caution on new shorts. Execution is best deferred into rallies toward the 9/20 EMA zone for rejection. The long-term uptrend stays intact above the rising 200-day SMA. Key risks include a relief bounce reclaiming the 20 EMA or a breakdown below the 200-day SMA invalidating core structural signals.

↑Breakthrough therapy designation and 100% early trial response rate accelerate BLA path.
↑Catalent manufacturing agreement ensures scalable supply for anticipated 2027 launch.
↓Net loss of $109M and $86.4M R&D spend in 2025 strain finances.

Full analysis →

Min Company Value

AI View

Min Insiders / Ticker

Hide Automated (10b5-1)

Date Range

Insider Trades13 trades

Date↓	Side	Ticker↕	Insider↕	Role↕	Shares↕	Price↕	Mkt Cap↕	52W High↕	52W Low↕	Value↕	% Chg↕	Rule↕	AI View↕
Jul 10, 2026	Sell	TSHA	Sukumar Nagendran	President and Head of R&D	200,000	$6.24	$1.6B	-31.23%	+85.20%	$1.2M	-17.60%	10b5-1	Trim
Apr 10, 2026	Sell	TSHA	Sukumar Nagendran	President and Head of R&D	219,021	$4.22	$1.6B	-31.23%	+85.20%	$924.5K	-5.82%	10b5-1	Trim
Feb 4, 2026	Sell	TSHA	Kamran Alam	CHIEF FINANCIAL OFFICER	1,655	$4.52	$1.6B	-31.23%	+85.20%	$7.5K	-0.11%	—	Trim
Jan 23, 2026	Sell	TSHA	Kamran Alam	CHIEF FINANCIAL OFFICER	102,817	$4.72	$1.6B	-31.23%	+85.20%	$485.0K	-3.41%	—	Trim
Jan 23, 2026	Sell	TSHA	Sukumar Nagendran	President and Head of R&D	116,050	$4.72	$1.6B	-31.23%	+85.20%	$547.5K	-4.18%	—	Trim
Jan 23, 2026	Sell	TSHA	Sean P. Nolan	Chief Executive Officer	178,101	$4.72	$1.6B	-31.23%	+85.20%	$840.2K	-2.95%	—	Trim
Jan 12, 2026	Sell	TSHA	Sukumar Nagendran	President and Head of R&D	400,000	$2.93	$1.6B	-31.23%	+85.20%	$1.2M	+0.00%	10b5-1	Trim
Nov 28, 2025	Sell	TSHA	Sukumar Nagendran	President and Head of R&D	740,344	$3.05	$1.6B	-31.23%	+85.20%	$2.3M	+0.00%	—	Trim
Sep 10, 2025	Sell	TSHA	Sukumar Nagendran	President and Head of R&D	241,150	$2.80	$1.6B	-31.23%	+85.20%	$674.8K	-5.96%	10b5-1	Trim
Aug 21, 2025	Sell	TSHA	Kamran Alam	CHIEF FINANCIAL OFFICER	54,491	$2.85	$1.6B	-31.23%	+85.20%	$155.3K	-4.39%	—	Trim
Aug 21, 2025	Sell	TSHA	Sukumar Nagendran	President and Head of R&D	57,054	$2.85	$1.6B	-31.23%	+85.20%	$162.6K	-4.67%	—	Trim
Mar 11, 2025	Sell	TSHA	Kamran Alam	CHIEF FINANCIAL OFFICER	29,843	$1.69	$1.6B	-31.23%	+85.20%	$50.4K	-2.35%	—	Trim
Feb 2, 2024	Sell	TSHA	Kamran Alam	CHIEF FINANCIAL OFFICER	1,288	$1.51	$1.6B	-31.23%	+85.20%	$1.9K	-0.15%	—	Trim